Melanogenesis and the Targeted Therapy of Melanoma

71Citations
Citations of this article
131Readers
Mendeley users who have this article in their library.

Abstract

Pigment production is a unique character of melanocytes. Numerous factors are linked with melanin production, including genetics, ultraviolet radiation (UVR) and inflammation. Understanding the mechanism of melanogenesis is crucial to identify new preventive and therapeutic strategies in the treatment of melanoma. Here, we reviewed the current available literatures on the mechanisms of melanogenesis, including the signaling pathways of UVR-induced pigment production, MC1R’s central determinant roles and MITF as a master transcriptional regulator in melanogenesis. Moreover, we further highlighted the role of targeting BRAF, NRAS and MC1R in melanoma prevention and treatment. The combination therapeutics of immunotherapy and targeted kinase inhibitors are becoming the newest therapeutic option in advanced melanoma.

Cite

CITATION STYLE

APA

Li, C., Kuai, L., Cui, R., & Miao, X. (2022, December 1). Melanogenesis and the Targeted Therapy of Melanoma. Biomolecules. MDPI. https://doi.org/10.3390/biom12121874

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free